Table of Contents

company-logo

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Trevi Therapeutics Dividend Announcement

• Trevi Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Trevi Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Trevi Therapeutics Dividend History

Trevi Therapeutics Dividend Yield

Trevi Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Trevi Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Trevi Therapeutics Financial Ratios

P/E ratio-7.00
PEG ratio1.10
P/B ratio5.26
ROE-63.30%
Payout ratio0.00%
Current ratio7.38
Quick ratio7.38
Cash Ratio1.76

Trevi Therapeutics Dividend FAQ

Does Trevi Therapeutics stock pay dividends?
Trevi Therapeutics does not currently pay dividends to its shareholders.
Has Trevi Therapeutics ever paid a dividend?
No, Trevi Therapeutics has no a history of paying dividends to its shareholders. Trevi Therapeutics is not known for its dividend payments.
Why doesn't Trevi Therapeutics pay dividends?
There are several potential reasons why Trevi Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Trevi Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Trevi Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Trevi Therapeutics a dividend aristocrat?
Trevi Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Trevi Therapeutics a dividend king?
Trevi Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Trevi Therapeutics a dividend stock?
No, Trevi Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Trevi Therapeutics stocks?
To buy Trevi Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Trevi Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.